Combination therapy with fluconazole and flucytosine for pulmonary cryptococcosis

Chemotherapy

Volumn 43, Issue 6, 1997, Pages 436-441

  Yamamoto, Yoshihiro ^a   Maesaki, Shigefumi ^a   Kakeya, Hiroshi ^a   Yanagihara, Katsunori ^a   Ohno, Hideaki ^a   Ogawa, Kazuhiro ^a   Hirakata, Youichi ^a   Tomono, Kazunori ^a   Koga, Hironobu ^a   Tashiro, Takayoshi ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Combination therapy; FIC index; Pulmonary cryptococcosis

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE;

ADULT; AGED; ANTIFUNGAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG POTENTIATION; FEMALE; HUMAN; KIDNEY FAILURE; LUNG INFECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

EID: 0030735592     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239603     Document Type: Article

References (13)

1. Maesaki S, Kohno S, Kaku M, Koga H, Hara K: Effects of antifungal agent combinations administered simultaneously and sequentially against Aspergillus fumigatus. An-timicrob Agents Chcmothcr 1994; 38:2843-2845.
2. Larsen R, Bozzette S, Jones B, Haghighat D, Leal M, Forthal D, Bauer M, Tilles J, McCutchan J, Lccdom J: Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1994; 19: 741-745.
3. Yamamoto Y, Kohno S, Koga H, Kakeya H, Tomono K, Kaku M, Ya-mazaki T, Arisawa M, Hara K: Random amplified polymorphic DNA analysis of clinical and environmentally isolated Cryptococcus neofor-mans in Nagasaki. J Clin Microbiol 1995;33:3328-3332.
4. Yamaguchi H, Uchida K, Kume H, Shinoda T, Watanabe K, Kusunoki T, Hiruma M, Ishizaki H: Report of the committee of clinical laboratory standards. Jpn J Med Mycol 1994; 26:61-86.
5. Dupont B, Drouhet E: In vitro synergy and antagonism of antifungal agents against yeast-like fungi. Postgrad MedJ 1979;55:683-686.
6. Larsen R, Leal M, Chan L: Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis: a randomized trial. Ann Intern Med 1990;113:183-187.
7. Tanaka K, Miyazaki T, Maesaki S, Mitsutake K, Kakeya H, Yamamoto Y, Yanagihara K, Hossain A, Tashi-ro T, Kohno S: Detection of Crypto-coccus neoformans gene in patients with pulmonary cryptococcosis. J Clin Microbiol 1996;34:2826-2828.
8. Tanaka K, Kohno S, Miyazaki T, Miyazaki H, Mitsutake K, Maesaki S, Kaku M, Koga H: The Eiken Latex test for detection of a cryptococcal antigen in cryptococcosis. Comparison with a monoclonal antibody-based latex agglutination test, Pastorex cyptococcus. Myccpatho-logia 1994;127:131-134
9. Bennett J, Dismukes W, Duma R, Medoff G, Sande M, Gallis H, Leonard J, Fields B, Bradshaw M, Maywood H, McGee Z, Cate T, Cobbs C, Warner J, Alling D: A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 1979,301:126-131.
10. Nguyen M, Narchicsi F, Mcgouch D, Yu V, Rinaldi M: In vitro evaluation of fluconazole and flucytosine against C. neoformans var. neoformans. Antimicrob Agents Chemo-ther 1995;39:1691-1695.
11. Denning D, Tucker R, Hanson L Jr H, Stevens D: Itraconazole therapy for cryptococcal meningitis and cryptococcoses. Arch Intern Med 1989;149:2301-2308.
12. Saag M, Powderly W, Cloud G, Robinson P, Grieco M, Sharkey P, Thompson S, Sugar A, Tuazon C, Fisher J, Hyslop N, Jacobson J, Hafner R, Dismukes W, the NIAID mycoses study group and the AIDS clinical trials group: Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associ-ated cryptococcal meningitis. N Engl J Med 1992;326:83-89.
13. Graybill J, Najvar L, Holmberg J, Correa A, Luther M: Fluconazole treatment of Candida albicans infection in mice: Does in vitro susceptibility predict in vivo response? Antimicrob Agents Chemother 1995; 39:1526-1529.